Cargando…
Opportunities for Antigen Discovery in Metastatic Breast Cancer
Immune checkpoint inhibitor-based immunotherapy (ICI) of breast cancer is currently efficacious in a fraction of triple negative breast cancers (TNBC) as these cancers generally carry high tumor mutation burden (TMB) and show increased tumor infiltration by CD8(+) T cells. However, most estrogen rec...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661635/ https://www.ncbi.nlm.nih.gov/pubmed/33193348 http://dx.doi.org/10.3389/fimmu.2020.570049 |